National Committee on Vital and Health Statistics: Meeting, 11375 [2020-03981]

Download as PDF Federal Register / Vol. 85, No. 39 / Thursday, February 27, 2020 / Notices 67. Brenda J. Underwood, Richmond, Virginia, Court of Federal Claims No: 20– 0104V 68. Dennis Vivians, Bethesda, Maryland, Court of Federal Claims No: 20–0105V 69. Wesley Faske, Houston, Texas, Court of Federal Claims No: 20–0106V 70. Elissa DiPasquale, Commack, New York, Court of Federal Claims No: 20–0108V 71. Eva Gordon, Dallas, Texas, Court of Federal Claims No: 20–0109V 72. Tina Schaum-Hoey, Baltimore, Maryland, Court of Federal Claims No: 20–0110V 73. Camila Wagner, Lone Tree, Colorado, Court of Federal Claims No: 20–0111V 74. Angela Bulan Bogue, Youngsville, North Carolina, Court of Federal Claims No: 20–0112V 75. Angela Bulan Bogue, Youngsville, North Carolina, Court of Federal Claims No: 20–0113V 76. Teresa Washington-Jenkins, Lancaster, Pennsylvania, Court of Federal Claims No: 20–0114V [FR Doc. 2020–03980 Filed 2–26–20; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES lotter on DSKBCFDHB2PROD with NOTICES National Committee on Vital and Health Statistics: Meeting Pursuant to the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) announces the following advisory committee meeting. NAME: National Committee on Vital and Health Statistics (NCVHS), Full Committee Meeting. DATES AND TIMES: Tuesday, March 24, 2020: 9:00 a.m.– 5:30 p.m. Wednesday, March 25, 2020: 8:30 a.m.– 3:00 p.m. PLACE: U.S. Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW, Rm. 505A, Washington, DC 20201. STATUS: Open. PURPOSE: At the March 24–25, 2020 meeting, the Committee will welcome four new NCVHS members, review and discuss a recent request received from the Designated Standard Maintenance Organizations (DSMO), receive briefings from HHS officials to inform discussion of the Committee’s workplan, and hold discussions on several health data policy topics. The Subcommittee on Standards will lead the Committee in a discussion of the most recent change request received from the DSMO taking into consideration input from stakeholders regarding costs and benefits of implementing the most recent version of the National Council for Prescription VerDate Sep<11>2014 17:26 Feb 26, 2020 Jkt 250001 11375 drug Programs (NCPDP) pharmacy standard (NCPDP F6). The Health Insurance Portability and Accountability Act (HIPAA) of 1996, as amended,1 gives statutory authority to the Secretary of Health & Human Services (HHS) to promulgate regulations adopting standards, code sets, and identifiers to support the exchange of electronic health information between covered entities. The standards are for retail pharmacy and medical transactions. New versions of the adopted standards may be brought forward to NCVHS by the standards development organizations (SDOs) or through the DSMO after completion of a consensus-based review and evaluation process. The Committee’s intent is to understand the changes in version F6 and whether there are substantive changes which need to be evaluated that would significantly change the Committee’s recommendation to HHS submitted in 2018. There is no change to the Batch Standard Implementation Guide Version 15 and the Subrogation Implementation Guide for Batch Standard Version 10, which were included in the May 2018 NCVHS recommendation. The Committee requests input and comments from the public in advance of this meeting to inform its deliberations about the benefits or costs of changing to this new version. The change request letter and change log are available for review at https://ncvhs.hhs.gov/Letter-to-NCVHSDSMO-Change-Request-January-212020. Please submit comments specific to the impact of the change from version F2 to F6 to NCVHSmail@cdc.gov by close of business Friday, March 13, 2020. The Subcommittee on Standards will introduce a new project scoping statement for its work on convergence of administrative and clinical data standards using the prior authorization transaction as a use-case. The Subcommittee will also provide an update on its activities in collaboration with the Office of the National Coordinator for Health Information Technology (ONC) and the Health Information Technology Advisory Committee (HITAC) regarding the opportunity for burden reduction through convergence of administrative and clinical data standards using the prior authorization transaction as a usecase. The Subcommittee on Privacy, Confidentiality and Security will lead a discussion of the full Committee to assess priority areas for focus and activity. HHS agencies will brief the Committee regarding recent and ongoing work to inform the Committee’s discussion of the 2020 workplan. There will be a public comment period on both meeting days. The times and topics are subject to change. Please refer to the posted agenda for any updates. CONTACT PERSON FOR MORE INFORMATION: Substantive program information may be obtained from Rebecca Hines, MHS, Executive Secretary, NCVHS, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Hyattsville, Maryland 20782, telephone (301) 458–4715. Summaries of meetings and a roster of Committee members are available on the home page of the NCVHS website: www.ncvhs.hhs.gov, where further information including an agenda and instructions to access the broadcast of the meeting will also be posted. Should you require reasonable accommodation, please contact the CDC Office of Equal Employment Opportunity on (770) 488–3210 as soon as possible. 1 Along with Section 1104 (c) of the Affordable Care Act. Name of Committee: National Institute of Allergy and Infectious Diseases Special PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Dated: February 20, 2020. Sharon Arnold, Associate Deputy Assistant Secretary for Planning and Evaluation, Science and Data Policy, Office of the Assistant Secretary for Planning and Evaluation. [FR Doc. 2020–03981 Filed 2–26–20; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

[Federal Register Volume 85, Number 39 (Thursday, February 27, 2020)]
[Notices]
[Page 11375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03981]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Committee on Vital and Health Statistics: Meeting

    Pursuant to the Federal Advisory Committee Act, the Department of 
Health and Human Services (HHS) announces the following advisory 
committee meeting.

NAME: National Committee on Vital and Health Statistics (NCVHS), Full 
Committee Meeting.

DATES AND TIMES: 
Tuesday, March 24, 2020: 9:00 a.m.-5:30 p.m.
Wednesday, March 25, 2020: 8:30 a.m.-3:00 p.m.

PLACE: U.S. Department of Health and Human Services, Hubert H. Humphrey 
Building, 200 Independence Avenue SW, Rm. 505A, Washington, DC 20201.

STATUS: Open.

PURPOSE: At the March 24-25, 2020 meeting, the Committee will welcome 
four new NCVHS members, review and discuss a recent request received 
from the Designated Standard Maintenance Organizations (DSMO), receive 
briefings from HHS officials to inform discussion of the Committee's 
workplan, and hold discussions on several health data policy topics.
    The Subcommittee on Standards will lead the Committee in a 
discussion of the most recent change request received from the DSMO 
taking into consideration input from stakeholders regarding costs and 
benefits of implementing the most recent version of the National 
Council for Prescription drug Programs (NCPDP) pharmacy standard (NCPDP 
F6).
    The Health Insurance Portability and Accountability Act (HIPAA) of 
1996, as amended,\1\ gives statutory authority to the Secretary of 
Health & Human Services (HHS) to promulgate regulations adopting 
standards, code sets, and identifiers to support the exchange of 
electronic health information between covered entities. The standards 
are for retail pharmacy and medical transactions. New versions of the 
adopted standards may be brought forward to NCVHS by the standards 
development organizations (SDOs) or through the DSMO after completion 
of a consensus-based review and evaluation process.
---------------------------------------------------------------------------

    \1\ Along with Section 1104 (c) of the Affordable Care Act.
---------------------------------------------------------------------------

    The Committee's intent is to understand the changes in version F6 
and whether there are substantive changes which need to be evaluated 
that would significantly change the Committee's recommendation to HHS 
submitted in 2018. There is no change to the Batch Standard 
Implementation Guide Version 15 and the Subrogation Implementation 
Guide for Batch Standard Version 10, which were included in the May 
2018 NCVHS recommendation. The Committee requests input and comments 
from the public in advance of this meeting to inform its deliberations 
about the benefits or costs of changing to this new version. The change 
request letter and change log are available for review at https://ncvhs.hhs.gov/Letter-to-NCVHS-DSMO-Change-Request-January-21-2020. 
Please submit comments specific to the impact of the change from 
version F2 to F6 to [email protected] by close of business Friday, 
March 13, 2020.
    The Subcommittee on Standards will introduce a new project scoping 
statement for its work on convergence of administrative and clinical 
data standards using the prior authorization transaction as a use-case. 
The Subcommittee will also provide an update on its activities in 
collaboration with the Office of the National Coordinator for Health 
Information Technology (ONC) and the Health Information Technology 
Advisory Committee (HITAC) regarding the opportunity for burden 
reduction through convergence of administrative and clinical data 
standards using the prior authorization transaction as a use-case.
    The Subcommittee on Privacy, Confidentiality and Security will lead 
a discussion of the full Committee to assess priority areas for focus 
and activity. HHS agencies will brief the Committee regarding recent 
and ongoing work to inform the Committee's discussion of the 2020 
workplan.
    There will be a public comment period on both meeting days. The 
times and topics are subject to change. Please refer to the posted 
agenda for any updates.

CONTACT PERSON FOR MORE INFORMATION: Substantive program information 
may be obtained from Rebecca Hines, MHS, Executive Secretary, NCVHS, 
National Center for Health Statistics, Centers for Disease Control and 
Prevention, 3311 Toledo Road, Hyattsville, Maryland 20782, telephone 
(301) 458-4715. Summaries of meetings and a roster of Committee members 
are available on the home page of the NCVHS website: www.ncvhs.hhs.gov, 
where further information including an agenda and instructions to 
access the broadcast of the meeting will also be posted.
    Should you require reasonable accommodation, please contact the CDC 
Office of Equal Employment Opportunity on (770) 488-3210 as soon as 
possible.

    Dated: February 20, 2020.
Sharon Arnold,
Associate Deputy Assistant Secretary for Planning and Evaluation, 
Science and Data Policy, Office of the Assistant Secretary for Planning 
and Evaluation.
[FR Doc. 2020-03981 Filed 2-26-20; 8:45 am]
 BILLING CODE 4150-05-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.